Haemonetics Beats Expectations with Strong Q2 Results
Update: 2025-11-06
Description
Haemonetics Corporation, a Boston-based blood management systems specialist, reported robust financial results for its fiscal second quarter. The company surpassed Wall Street expectations with a profit of eighty-one cents per share, adjusted to one dollar and twenty-seven cents per share. Revenue also exceeded forecasts, reaching three hundred twenty-seven point three million dollars. Haemonetics projects full-year earnings between four dollars and eighty cents to five dollars per share, indicating continued growth and market confidence.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
